Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists

Azziz, 2004, The prevalence and features of the polycystic ovary syndrome in an unselected population, J Clin Endocrinol Metab, 89, 2745, 10.1210/jc.2003-032046 Ehrmann, 2006, Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 48, 10.1210/jc.2005-1329 Diamanti-Kandarakis, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile, J Clin Endocrinol Metab, 84, 4006, 10.1210/jc.84.11.4006 Asunción, 2000, A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain, J Clin Endocrinol Metab, 85, 2434, 10.1210/jc.85.7.2434 American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee, 2005, American Association of Clinical Endocrinologists Position Statement on metabolic and cardiovascular consequences of polycystic ovary syndrome, Endocr Pract, 11, 126 Ehrmann, 1999, Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome, Diabetes Care, 22, 141, 10.2337/diacare.22.1.141 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098 ACOG Committee on Practice Bulletins—Gynecology, 2009, ACOG Practice Bulletin No. 108: polycystic ovary syndrome. Obstet Gynecol, Obstet Gynecol, 114, 936, 10.1097/AOG.0b013e3181bd12cb Wang, 2011, Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia, Obstet Gynecol, 117, 6, 10.1097/AOG.0b013e31820209bb Hudecova, 2011, Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome—a long term follow-up, Hum Reprod, 26, 1462, 10.1093/humrep/der065 Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, 38, 1165, 10.2337/diabetes.38.9.1165 Carmina, 2004, Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome, Fertil Steril, 82, 661, 10.1016/j.fertnstert.2004.01.041 Ovalle, 2002, Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus, Fertil Steril, 77, 1095, 10.1016/S0015-0282(02)03111-4 Wild, 2010, Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society, J Clin Endocrinol Metab, 95, 2038, 10.1210/jc.2009-2724 Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165, 10.1210/jc.84.1.165 Salley, 2007, Glucose intolerance in polycystic ovary syndrome—a position statement of the Androgen Excess Society, J Clin Endocrinol Metab, 92, 4546, 10.1210/jc.2007-1549 Azziz, 2006, Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 Gavin III J, Alberti K, Davidson M, et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183–97. American Diabetes Association, 2010, Standards of medical care in diabetes—2010, Diabetes Care, 33, S11, 10.2337/dc10-S011 American Diabetes Association, 2009, Standards of medical care in diabetes—2009, Diabetes Care, 32, S13, 10.2337/dc09-S013 Carlfjord, 2010, Key factors influencing adoption of an innovation in primary health care: a qualitative study based on implementation theory, BMC Fam Pract, 11, 60, 10.1186/1471-2296-11-60 Holte, 1994, Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance, J Clin Endocrinol Metab, 78, 1052, 10.1210/jc.78.5.1052 International Expert Committee, 2009, International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, 32, 1327, 10.2337/dc09-9033 Yildiz, 2008, Impact of obesity on the risk for polycystic ovary syndrome, J Clin Endocrinol Metab, 93, 162, 10.1210/jc.2007-1834